EFTR - Effector Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

EFTR is currently covered by 3 analysts with an average price target of $9.88. This is a potential upside of $9.88 (0%) from yesterday's end of day stock price of $0.

Effector Therapeutics's activity chart (see below) currently has 12 price targets and 20 ratings on display. The stock rating distribution of EFTR is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 35% with an average time for these price targets to be met of 235.6 days.

Highest price target for EFTR is $1, Lowest price target is $1, average price target is $9.88.

Most recent stock forecast was given by BENJAMIN BURNETT from STIFEL on 26-May-2023. First documented stock forecast 13-Sep-2021.

Best performing analysts who are covering EFTR - Effector Therapeutics:

Judah Frommer Reni Benjamin Benjamin Burnett Mara Goldstein Louise Chen

Currently out of the existing stock ratings of EFTR, 7 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$1.3

$0.13 (11.11%)

1 years 5 months 27 days ago
(26-May-2023)

1/3 (33.33%)

$0.64 (96.97%)

11

Buy

1 years 6 months 12 days ago
(10-May-2023)

2/3 (66.67%)

$9.66 (222.58%)

740

Buy

$1

$-0.17 (-14.53%)

$2

1 years 10 months 13 days ago
(09-Jan-2023)

3/4 (75%)

$0.6 (150.00%)

427

Buy

2 years 5 months 16 days ago
(06-Jun-2022)

0/2 (0%)

$30.7 (159.07%)

Buy

2 years 7 months 19 days ago
(04-Apr-2022)

0/1 (0%)

$7.79 (63.80%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is EFTR (Effector Therapeutics) average time for price targets to be met?

On average it took 235.6 days on average for the stock forecasts to be realized with a an average price target met ratio 35

Which analyst has the current highest performing score on EFTR (Effector Therapeutics) with a proven track record?

JUDAH FROMMER

Which analyst has the current lower performing score on EFTR (Effector Therapeutics) with a proven track record?

LOUISE CHEN

Which analyst has the most public recommendations on EFTR (Effector Therapeutics)?

Judah Frommer works at MORGAN STANLEY and has 15 price targets and 8 ratings on EFTR

Which analyst is the currently most bullish on EFTR (Effector Therapeutics)?

Benjamin Burnett with highest potential upside - $0.13

Which analyst is the currently most reserved on EFTR (Effector Therapeutics)?

Reni Benjamin with lowest potential downside - -$0.17

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?